01 / GUIDES
Player-centered guides
In-depth guides organize the questions that can matter to current and former football players: health history, brain injury concerns, medication interactions, cardiac risk, legal exposure, and the limits of available evidence.
Our football-specific ibogaine overview keeps those subjects in one place without presenting ibogaine as a simple answer.
02 / DECISION FRAMEWORKS
Questions before action
Decision frameworks help turn an urgent, emotional question into a sequence of practical issues: what is being considered, what risks may be relevant, what information is missing, and which qualified professionals should be involved.
They are not clinical screening. They are a way to recognize that treatment facility choices in Mexico can raise medical, travel, and legal questions at once.
03 / COMPARISONS
Clearer comparisons
Comparisons explain how terms, settings, and public claims can differ. They help readers distinguish a name, a location, a treatment claim, and a safety claim rather than treating them as interchangeable.
Our terminology work includes a plain-language look at other names used for ibogaine, so searches and conversations begin with fewer assumptions.
04 / RESEARCH SUMMARIES
Evidence with boundaries
Research summaries place individual studies and public narratives beside their limits. In the United States, ibogaine remains a Schedule I controlled substance under federal law, a status reflected by the Drug Enforcement Administration’s scheduling information.
We also compare the questions people ask about ibogaine treatment centers in the United States with the practical constraints that may affect them.